Virginia Retirement Systems’s Aclaris Therapeutics ACRS Stock Holding History

Virginia Retirement Systems’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$186K	Buy	+27,200	New	+$232K	﹤0.01%	888

Other funds holding ACRS

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virginia Retirement Systems's ACRS Position: Q3 2023 in Review

Virginia Retirement Systems opened a new position in Aclaris Therapeutics (ACRS) in Q3 2023: 27,200 shares worth $186K. The stake represents ﹤0.01% of the portfolio and ranks #888 among its holdings.

137 funds tracked by Wall St. Rank hold ACRS as of Q3 2023.

Virginia Retirement Systems held 27,200 shares of Aclaris Therapeutics worth $186K as of Q3 2023.
Aclaris Therapeutics was a new Virginia Retirement Systems position in Q3 2023.
Aclaris Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #888 holding.
137 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.